Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 151
Filtrar
1.
Int. j. clin. health psychol. (Internet) ; 24(1): [100413], Ene-Mar, 2024. tab, graf, ilus
Artigo em Inglês | IBECS | ID: ibc-230359

RESUMO

Both the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) rTMS have the potential to reduce certain chronic pain conditions. However, the analgesic mechanisms remain unclear, in which M1- and DLPFC-rTMS may have different impact on the release of dopamine receptor D2 neurotransmissions (DRD2). Using a double-blind, randomised, sham- and placebo-controlled design, this study investigated the influence of DRD2 antagonist on rTMS-induced analgesia and corticospinal excitability across the M1 and DLPFC. Healthy participants in each group (M1, DLPFC, or Sham) received an oral dose of chlorpromazine or placebo before the delivery of rTMS in two separate sessions. Heat pain and cortical excitability were assessed before drug administration and after rTMS intervention. DRD2 antagonist selectively abolished the increased heat pain threshold induced by DLPFC stimulation and increased pain unpleasantness. The absence of analgesic effects in DLPFC stimulation was not accompanied by plastic changes in the corticospinal pathway. In contrast, DRD2 antagonist increased corticospinal excitability and rebalanced excitation-inhibition relationship following motor cortex stimulation, although there were no clear changes in pain experiences. These novel findings together highlight the influence of dopaminergic neurotransmission on rTMS-induced analgesia and corticospinal excitability dependent on stimulation targets.(AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Dor Crônica , Manejo da Dor , Receptores de Dopamina D2 , Dopamina , Psicologia Clínica , Ensaios Clínicos Controlados Aleatórios como Assunto
2.
Enferm. clín. (Ed. impr.) ; 34(1): 56-60, Ene-Feb, 2024. tab
Artigo em Espanhol | IBECS | ID: ibc-229657

RESUMO

Objetivo: Muchos adultos mayores en Indonesia deciden vivir en residencias de ancianos. Vivir en un hogar de ancianos ha sido asociado al deterioro cognitivo en adultos mayores, afectando a la capacidad para llevar a cabo actividades de la vida diaria. Este estudio tuvo como objetivo determinar la asociación entre características demográficas y clínicas y la función cognitiva en adultos mayores que viven una residencia de ancianos en Indonesia. Método: Este estudio utilizó un diseño transversal, participando 60 adultos mayores de una residencia de ancianos. La función cognitiva se evaluó utilizando el instrumento Montreal Cognitive Assessment. Se evaluaron características demográficas y clínicas como edad, nivel educativo, tiempo de permanencia en la residencia, así como niveles séricos de factor neurotrófico derivado del cerebro y dopamina. Se utilizó la prueba de Spearman-rank para el análisis de datos. Resultados: La función cognitiva de atención se correlacionó positivamente con la edad (r=0,314, p=0,015) y el tiempo de permanencia en la residencia (r=0,268, p=0,038), y negativamente con los niveles séricos de dopamina (r=–0,425, p=0,001). La función cognitiva de denominación se relacionó positivamente con la edad (r=0,263, p=0,042). Conclusiones: Edad, tiempo de internado y niveles de dopamina se asociaron a la función cognitiva en adultos mayores que viven en una residencia de ancianos. El adulto mayor debe ser evaluado en cuanto a factores asociados a la función cognitiva, para realizar los programas de mejora cognitiva en residencias de ancianos.(UA)


Objective: Many older adults in Indonesia decide to live in nursing homes. Living in a nursing home has been associated with the incidence of cognitive decline in older adult that leads to decreasing ability to perform daily activity. This study aimed to determine the association between demographic and clinical characteristics with cognitive functions in older adults living in nursing homes in Indonesia. Methods: This study used a cross-sectional design and involved 60 older adults in a nursing home. Cognitive function was evaluated using the Montreal Cognitive Assessment instrument. Demographic and clinical characteristics such as age, education level, length of stay in the nursing home, as well as serum levels of brain-derived neurotrophic factor and dopamine were studied. Spearman-Rank test was used for data analysis. Results: Cognitive function of attention had a positive correlation with age (r=0.314, p=0.015), length of stay in the nursing home (r=0.268, p=0.038), and negative correlation with dopamine serum levels (r=-0.425, p=0.001). The cognitive function of naming has a positive correlation with age (r=0.263, p=0.042). Conclusions: Age, length of stay, and dopamine levels associated with cognitive function in older adult living in nursing homes. The older adult should be assessed in term of factors associated with cognitive function to make the cognitive improvement programs in nursing homes.(AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Instituição de Longa Permanência para Idosos , Cognição , Disfunção Cognitiva , Saúde do Idoso , Dopamina , Fator Neurotrófico Derivado do Encéfalo , Saúde do Idoso Institucionalizado , Saúde Mental , Indonésia , Estudos Transversais
3.
Prev. tab ; 25(2): 55-56, Abril/Junio 2023.
Artigo em Espanhol | IBECS | ID: ibc-223578
5.
Rev. esp. anestesiol. reanim ; 69(4): 249-252, Abr 2022. ilus, graf
Artigo em Espanhol | IBECS | ID: ibc-205053

RESUMO

El feocromocitoma es un tumor neuroendocrino raro que se origina en las células cromafines de la cresta neural del sistema nervioso autónomo. La mayoría de las feocromocitomas se caracterizan por secretar adrenalina y noradrenalina. Los productores de dopamina son infrecuentes y no presentan la sintomatología clínica típica, por lo que el diagnóstico puede ser complicado. Actualmente disponemos de escasa bibliografía sobre el manejo anestésico de este tipo de tumores.Presentamos el caso clínico de una mujer de 41 años que acudió a nuestro centro por dolor lumbar de tipo cólico de un mes de evolución y normotensión. Se realizó una tomografía axial computarizada abdominal que reveló masa hipercaptante en glándula suprarrenal izquierda. Los niveles de dopamina en orina y en plasma estaban elevados, los niveles de adrenalina y noradrenalina eran normales. Durante la intervención quirúrgica la paciente se mantuvo hipotensa precisando dosis de noradrenalina. Solo presentó un único pico hipertensivo durante la laringoscopia y la intubación orotraqueal.(AU)


Pheochromocytomas are rare neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla. Most adrenal pheochromocytomas secrete norepinephrine and epinephrine. Dopamine secreting pheochromocytomas are extremely rare and differs from classic pheochromocytomas in clinical features, posing a significant diagnostic challenge.A 41-year-old women presented to our emergency department because of acute flank colic pain and normotension. The screening abdominal computed tomography scan revealed a left adrenal mass. The laboratory test showed significantly increase in plasma dopamine and 24-hour urine dopamine. During surgical removal the patient remained hypotensive requiring doses of norepinephrine. The patient presented significant hypertensive responde during direct laryngoscopy and intubation.(AU)


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Feocromocitoma , Dopamina , Tumores Neuroendócrinos , Sistema Nervoso Autônomo , Dor Lombar , Catecolaminas , Adrenalectomia , Cirurgia Geral , Anestesiologia
6.
Eur. j. psychiatry ; 35(4): 225-233, octubre-diciembre 2021.
Artigo em Inglês | IBECS | ID: ibc-217635

RESUMO

Background and Objectives: From a gene-by-environment perspective, parenting in interaction with the polymorphism in the Monoamine oxidase A (MAOA) gene (MAOA-uVNTR) might also be associated with increased callous-unemotional traits (CU) in preschoolers. MAOA-uVNTR results in differential enzyme activity, so that high-activity alleles (MAOA-H) are linked to reduced dopamine, serotonin, and norepinephrine availability in comparison to low-activity allele (MAOA-L). As MAOA-uVNTR has been previously described to moderate the relationship between childhood parental maltreatment and aggressive and antisocial behavior, it may also play a role in CU traits etiology.MethodsData was collected through questionnaires answered by parents and teachers. MAOA-uVNTR was genotyped in 368 Caucasian children from a community sample (51.9% male). Multiple linear regression analyses were conducted to analyze the interaction effect of MAOA genotypes and both positive parenting and punitive parenting practices on CU traits at two different periods (3 and 5 years old) and separately by sex.ResultsNo significant interactions were found for boys. Among girls, a significant interaction effect was found for MAOA-LL carriers, who showed higher CU traits at age 5 when exposed to higher punitive or positive parenting at age 3.ConclusionsOur study provides the first evidence for significant MAOA × early parenting effects on CU traits in preschoolers, specifically among female MAOA-LL carriers. This suggests that the MAOA-LL genotype for girls is associated with higher sensitivity to both positive and punitive parenting in girls, so that MAOA-LL emerges as a genotype that confers higher vulnerability to parental influences. (AU)


Assuntos
Humanos , Cruzamento , Polimorfismo Genético , Serotonina , Dopamina , Norepinefrina
10.
J. optom. (Internet) ; 13(2): 74-80, abr.-jun. 2020.
Artigo em Inglês | IBECS | ID: ibc-196802

RESUMO

Evaluations of tear functions frequently involve some form of voluntary control over blink behaviour. To the degree that voluntary control of blinking risks departure from normal-range spontaneous blinking, the tear function findings from such studies may be confounded. Even subject awareness that blinking is being assessed may influence findings if such awareness results in any degree of voluntary control. Ideally, the influence on blink rate and tear functions induced by therapeutic or experimental interventions could be measured against a normal-range baseline spontaneous blink rate in order that any differences found could be validly attributed to those interventions. Sometimes pre-intervention 'rest-related' baseline blink rates have been incorrectly described as 'basal' blink rates without specification of pre-intervention conditions of 'rest' or consideration of any contributions from voluntary control. Also, studies which use only blink rates to measure blink efficiency ignore the critically important contribution of incomplete blinking to blink inefficiency. This review finds that the assessment of normal-range spontaneous blink rates depends on measurement conditions which have frequently been ignored previously. For example, normal-range spontaneous blink rates appear more likely to occur with fixation targets which have a disengaged affect and an associated neutral influence on and from dopamine activity. Ideally, fixation targets should also involve minimal cognitive loading and vision demands. In addition, normal-range (symptom free) spontaneous blink rates are more likely to be assessed in a comfortable ambient environment without subject awareness that blink behaviour is being assessed and when voluntary blinking is not involved


Las valoraciones de las funciones de la lágrima incluyen alguna forma de control voluntario del parpadeo. Hasta el punto de que el control voluntario del parpadeo puede tener su origen en el parpadeo espontáneo de rango normal, los hallazgos sobre función de la lágrima de dichos estudios pueden resultar confusos. Incluso la concienciación del sujeto acerca de que se está evaluando el parpadeo puede influir en los hallazgos, cuando dicha concienciación deriva en cualquier grado de control voluntario. De forma ideal, la influencia sobre las tasas de parpadeo y las funciones de la lágrima inducidas por intervenciones terapéuticas o experimentales podría medirse frente a una tasa de parpadeo espontáneo basal de rango normal, a fin de poder atribuir válidamente cualesquiera diferencias a dichas intervenciones. A veces, las tasas de parpadeo de referencia "relacionadas con el descanso" pre-intervención se han descrito incorrectamente como tasas de parpadeo "basal", sin especificar las condiciones "de descanso" pre-intervención, o la consideración de cualquier contribución del control voluntario. De igual modo, los estudios que utilizan únicamente tasas de parpadeo para medir la eficiencia del parpadeo, ignoran la contribución críticamente importante del parpadeo incompleto sobre la ineficiencia del mismo. Esta revisión encuentra que la valoración de las tasas de parpadeo espontáneo de rango normal depende de las condiciones de medición, que con frecuencia han sido ignoradas previamente. Por ejemplo, es más probable que se produzcan tasas de parpadeo espontáneo de rango normal con objetivos de fijación, que tienen un efecto de desactivación y una influencia neutra asociada sobre la actividad de la dopamina. De manera ideal, los objetivos de fijación deberían implicar también una carga cognitiva mínima y unas demandas de visión. Además, es más probable que las tasas de parpadeo espontáneo de rango normal (con ausencia de síntomas) se valoren en un entorno confortable, sin que el sujeto sea consciente de que se está valorando el parpadeo, y cuando el parpadeo voluntario no se ve implicado


Assuntos
Humanos , Piscadela/fisiologia , Lágrimas/fisiologia , Dopamina/fisiologia
11.
Rev. Soc. Esp. Dolor ; 26(3): 184-198, mayo-jun. 2019. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-190900

RESUMO

La enfermedad de Parkinson (EP) es una enfermedad neurodegenerativa, la segunda con mayor prevalencia después de la enfermedad de Alzheimer. Presenta tanto síntomas motores como no motores; entre estos últimos se encuentran disfunción autonómica, dolor inexplicable, deterioro cognitivo, ansiedad, depresión, entre otros. Algunos de estos pacientes experimentan el dolor como un síntoma temprano de Parkinson, incluso antes de la expresión de su enfermedad. Entre las personas que tienen EP y que experimentan dolor, lo describen como un síntoma preocupante, siendo una causa de sufrimiento y de incapacidad. Sin embargo, a pesar de ello, el dolor en la EP a menudo permanece sin diagnóstico y sin tratamiento. Por tanto, es importante entender que el dolor puede ser parte de la experiencia del Parkinson y aprender las formas de manejarlo. Este trabajo revisa datos actuales sobre posibles mecanismos, clasificaciones, evolución, factores de riesgo potenciales y control del dolor en la EP. El mecanismo del dolor en esta situación es complejo, y está influenciado por distintos factores, pudiendo estar vinculado a cambios patológicos en las estructuras anatómicas involucradas en mecanismos nociceptivos


Parkinson's disease (PD) is a neurodegenerative disease, the second most prevalent, after Alzheimer's disease. It presents both motor and non-motor symptoms; These include autonomic dysfunction, unexplained pain, cognitive impairment, anxiety, depression, among others. Some of these patients experience pain as an early symptom of Parkinson's, even before the expression of their disease. Among people who have PD and who experience pain, they describe it as a worrisome symptom, being a cause of suffering and disability. However, despite this, pain in PD often remains undiagnosed and untreated. Therefore, it is important to understand that pain can be part of the Parkinson's experience and learn ways to manage it. This paper reviews current data on possible mechanisms, classifications, evolution, potential risk factors and pain control in PD. The mechanism of pain in this situation is complex, and is influenced by different factors, which may be linked to pathological changes in the anatomical structures involved in nociceptive mechanisms


Assuntos
Humanos , Doença de Parkinson/complicações , Dor Musculoesquelética/epidemiologia , Distonia/complicações , Agitação Psicomotora/complicações , Dor Musculoesquelética/etiologia , Manejo da Dor/métodos , Dopamina/metabolismo , Acetilcolina/metabolismo , Proteínas de Ligação ao GTP/metabolismo
12.
J. physiol. biochem ; 74(4): 667-677, nov. 2018. graf, ilus, tab
Artigo em Inglês | IBECS | ID: ibc-179044

RESUMO

The adrenomedullary chromaffin cells' hormonal pathway has been related to the pathophysiology of diabetes mellitus. In mice, the deletion of insulin receptor substrate type 2 (Irs2) causes peripheral insulin resistance and reduction in Beta-cell mass, leading to overt diabetes, with gender differences on adrenergic signaling. To further unravel the relevance of Irs2 on glycemic control, we analyzed in adult Irs2 deficient (Irs2-/-) mice, of both sexes but still normoglycemic, dopamine effects on insulin secretion and glycerol release, as well as their adrenal medulla by an immunohistochemical and morphologic approach. In isolated islets, 10 μM dopamine significantly inhibited insulin release in wild-type (WT) and female Irs2−/− mice; however, male Irs2−/− islets were insensitive to that catecholamine. Similarly, on isolated adipocytes, gender differences were observed between WT and Irs2-/- mice in basal and evoked glycerol release with crescent concentrations of dopamine. By immunohistochemistry, reactivity to tyrosine hydroxylase (TH) in female mice was significantly higher in the adrenal medulla of Irs2-/- compared to WT; although no differences for TH-immunopositivity were observed between the male groups of mice. However, compared to their corresponding WT animals, adrenomedullary chromaffin cells of Irs2-/- mice showed a significant decrease in the cellular and nuclear areas, and even in their percentage of apoptosis. Therefore, our observations suggest that, together with gender differences on dopamine responses in Irs2-/- mice, disturbances in adrenomedullary chromaffin cells could be related to deficiency of Irs2. Accordingly, Irs2 could be necessary for adequate glucose homeostasis and maintenance of the population of the adrenomedullary chromaffin cells


Assuntos
Animais , Masculino , Feminino , Camundongos , Medula Suprarrenal/metabolismo , Dopamina/metabolismo , Hiperinsulinismo/metabolismo , Proteínas Substratos do Receptor de Insulina/metabolismo , Proteínas Substratos do Receptor de Insulina/metabolismo , Ilhotas Pancreáticas/metabolismo , Estado Pré-Diabético/metabolismo , Adipócitos Brancos , Hiperinsulinismo/sangue , Hiperinsulinismo/patologia , Técnicas In Vitro , Proteínas Substratos do Receptor de Insulina/genética , Ilhotas Pancreáticas/patologia , Estado Pré-Diabético/patologia
13.
Nutr. hosp ; 35(1): 194-200, ene.-feb. 2018. graf, ilus
Artigo em Inglês | IBECS | ID: ibc-172108

RESUMO

Objective: The aim of this study was to evaluate the effect of splenda and stevia on dopamine and 5-HIAA levels, and some biomarkers of oxidative stress in the presence of cytarabine. Methods: Forty-eight young male Wistar rats each with a weight of 80 g (four weeks of age), distributed in six groups of eight animals each, were treated as follows: group 1, control (NaCl 0.9% vehicle); group 2, cytarabine (0.6 g/kg); group 3, stevia (0.6 g/kg); group 4, cytarabine + stevia; group 5, splenda; and group 6, cytarabine + splenda. Cytarabine was given intravenously (IV) while stevia and splenda were administered orally for five days, using orogastric tube. At the end of treatment, the animals were sacrificed and glucose levels in blood were measured. The brains were dissected for histological analysis and homogenated to measure levels of dopamine, lipid peroxidation (TBARS), serotonin metabolite (5-HIAA), Na+, K+ ATPase activity, and glutathione (GSH), using validated methods. Results: Sweeteners increased the glucose in animals that received cytarabine. Dopamine increased in cortex and decreased in striatum of animals that received stevia alone and combined with cytarabine. 5-HIAA decreased in striatum and cerebellum/medulla oblongata of animals that received sweeteners and cytarabine alone or combined. GSH increased in animals that received sweeteners and decreased with cytarabine. Lipoperoxidation decreased in groups that received sweeteners and cytarabine. Histopathological changes revealed marked degeneration of neuronal cells in animals treated with cytarabine. Conclusion: These results show that sweeteners as stevia or splenda may lead to the onset of unfavorable changes in dopamine and 5-HIAA. Antioxidant effects may be involved. Besides, histological changes revealed marked lesions of neuronal cells in experimental animals treated with cytarabine (AU)


Objetivo: el objetivo fue evaluar el efecto de edulcorantes (splenda y stevia) sobre los niveles de dopamina, acido 5-hidroxiindolacetico (HIAA) y algunos biomarcadores de estrés oxidativo en presencia de citarabina. Métodos: cuarenta y ocho ratas Wistar machos con un peso aproximado de 80 g (cuatro semanas de edad), distribuidas en seis grupos de ocho animales cada uno, fueron tratados como sigue: grupo 1, control (NaCl 0,9% vehículo); grupo 2, citarabina (0,6 g/kg); grupo 3, stevia (0,6 g/kg); grupo 4, citarabina + stevia; grupo 5, splenda; y el grupo 6, citarabina + splenda. La citarabina fue administrada por vía intravenosa y la stevia y la splenda, por vía oral durante cinco días, utilizando una sonda orogastrica. Al final del tratamiento, los animales fueron sacrificados y se midieron los niveles de glucosa en sangre. Los cerebros fueron disecados para su análisis histológico y homogenizados para medir los niveles de dopamina, peroxidacion lipidica (TBARS), metabolito de la serotonina (5-HIAA), actividad de la Na+, K+ ATPasa y glutatión (GSH), usando métodos validados. Resultados: los edulcorantes aumentaron la glucosa en los animales que recibieron citarabina. La dopamina aumento en la corteza y disminuyo en el estriado de los animales que recibieron stevia sola y combinada con citarabina. La 5-HIAA disminuyo en el estriado y el cerebelo/ medula oblongata de animales que recibieron edulcorantes y citarabina sola o combinada. El GSH se incrementó en los animales que recibieron edulcorantes. La lipoperoxidacion disminuyo en los grupos que recibieron edulcorantes y citarabina. Estudios histopatológicos revelaron una degeneración neuronal importante en animales tratados con citarabina. Conclusión: los resultados muestran que los edulcorantes como stevia o splenda pueden conducir a la aparición de cambios desfavorables en los niveles de dopamina y 5-HIAA. Los cambios histológicos revelaron, además, lesiones marcadas de células neuronales en animales tratados con citarabina (AU)


Assuntos
Animais , Ratos , Cérebro , Citarabina/farmacocinética , Edulcorantes/farmacocinética , Interações Medicamentosas , Modelos Animais de Doenças , Dopamina , Receptores Dopaminérgicos , Peroxidação de Lipídeos , Glicemia , Estresse Oxidativo , Neurônios
14.
Rev. neurol. (Ed. impr.) ; 65(11): 507-519, 1 dic., 2017. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-169962

RESUMO

Introducción. La inhibición por prepulso (IPP) de la respuesta de sobresalto es una medida de sincronización sensitivomotora basada en la respuesta del reflejo de sobresalto. Un déficit en la IPP se ha observado en pacientes psiquiátricos, especialmente con esquizofrenia, así como en sujetos vulnerables a desarrollarla. Asimismo, los consumidores de cocaína presentan un alto índice de patologías psiquiátricas como la esquizofrenia. Objetivo. Conocer las alteraciones que el consumo de cocaína puede producir en la IPP. Desarrollo. Se realiza una revisión exhaustiva de los estudios, tanto clínicos como con modelos animales, que hayan evaluado la IPP tras el consumo o la administración de cocaína. Se sugieren bases neurales y mecanismos de acción subyacentes para explicar los resultados. Conclusiones. La cocaína altera la IPP a través de su acción sobre el sistema dopaminérgico. La administración aguda de cocaína disminuye la IPP al aumentar la dopamina, mientras que con el consumo crónico, dependiendo del tiempo de abstinencia, la IPP puede restablecerse. Sin embargo, los efectos de la cocaína sobre la IPP parecen depender de los niveles basales de la IPP que muestre el individuo. Así, dado que un déficit en la IPP se ha relacionado con una mayor vulnerabilidad a desarrollar patologías mentales como la esquizofrenia, los niveles de la IPP en los sujetos podrían considerarse como un biomarcador de vulnerabilidad psiquiátrica. Por ello, conocer mejor el efecto que drogas como la cocaína ejercen sobre la IPP puede ayudar a comprender el desarrollo de la patología dual (AU)


Introduction. Prepulse inhibition (PPI) of the startle response is an index used to evaluate how the pre-attention system. works. PPI is altered in patients with a mental disorder such as schizophrenia and in subjects who are vulnerable to it. Likewise, cocaine users also frequently exhibit psychiatric disorders as schizophrenia. Aim. To know the alterations that cocaine produces on PPI. Development. A comprehensive review is carried out, covering both clinical and preclinical studies with animal models that have evaluated the effects of cocaine exposure on the PPI paradigm. Underlying neural bases and mechanisms of action are suggested to explain these findings. Conclusions. Cocaine alters PPI through its action on the dopaminergic system. Acute exposure of cocaine decreases PPI by increasing dopamine, while with chronic use, depending on withdrawal time, PPI can be restored. However, the effects of cocaine on PPI appear to depend on the baseline levels of PPI shown by the individual. Thus, since a deficit in PPI has been associated with a greater vulnerability to developing mental pathologies such as schizophrenia, PPI level in subjects could be considered as a biomarker of psychiatric vulnerability. Therefore, a better understanding of the effect of drugs such as cocaine on PPI may help to understand the development of dual pathology (AU)


Assuntos
Humanos , Cocaína/farmacocinética , Inibição Pré-Pulso , Reflexo de Sobressalto , Transtornos Mentais/complicações , Transtornos Relacionados ao Uso de Cocaína/diagnóstico , Diagnóstico Duplo (Psiquiatria)/estatística & dados numéricos , Esquizofrenia/epidemiologia , Dopamina , Neurobiologia/métodos
15.
J. physiol. biochem ; 73(3): 395-404, ago. 2017. graf, ilus, tab
Artigo em Inglês | IBECS | ID: ibc-178891

RESUMO

Dopamine (DA) acts as gut motility modulator, via D1- and D2-like receptors, but its effective role is far from being clear. Since alterations of the dopaminergic system could lead to gastrointestinal dysfunctions, a characterization of the enteric dopaminergic system is mandatory. In this study, we investigated the role of DA and D1- and D2-like receptors in the contractility of the circular muscle of mouse distal colon by organ-bath technique. DA caused relaxation in carbachol-precontracted circular muscle strips, sensitive to domperidone, D2-like receptor antagonist, and mimicked by bromocriptine, D2-like receptor agonist. 7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH-23390), D1-like receptor antagonist, neural toxins, L-NAME (nitric oxide (NO) synthase inhibitor), 2'-deoxy-N6-methyl adenosine 3',5'-diphosphate diammonium salt (MRS 2179), purinergic P2Y1 antagonist, or adrenergic antagonists were ineffective. DA also reduced the amplitude of neurally evoked cholinergic contractions. The effect was mimicked by (±)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide (SKF-38393), D1-like receptor agonist and antagonized by SCH-23390, MRS 2179, or L-NAME. Western blotting analysis determined the expression of DA receptor proteins in mouse distal colon. Notably, SCH-23390 per se induced an increase in amplitude of spontaneous and neurally evoked cholinergic contractions, unaffected by neural blockers, L-NAME, MRS 2179, muscarinic, adrenergic, or D2-like receptor antagonists. Indeed, SCH-23390-induced effects were antagonized by an adenylyl cyclase blocker. In conclusion, DA inhibits colonic motility in mice via D2- and D1-like receptors, the latter reducing acetylcholine release from enteric neurons, involving nitrergic and purinergic systems. Whether constitutively active D1-like receptors, linked to adenylyl cyclase pathway, are involved in a tonic inhibitory control of colonic contractility is questioned


Assuntos
Animais , Masculino , Colo/fisiologia , Dopamina/farmacologia , Contração Muscular , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/metabolismo , Colo , Antagonistas de Dopamina/farmacologia , Agonistas de Dopamina/farmacologia , Motilidade Gastrointestinal , Camundongos Endogâmicos C57BL
16.
Span. j. psychol ; 20: e13.1-e13.9, 2017. tab
Artigo em Inglês | IBECS | ID: ibc-160556

RESUMO

Intense effort is directed toward searching for associations between genes and neuropsychological measures of executive functions. In contrast, the impact of genetic polymorphisms on self-rating of everyday executive functioning has not been investigated so far. This study was designed to test associations of self-reported executive functioning, measured with the Behavior Rating Inventory of Executive Function (BRIEF-A), with dopaminergic and serotoninergic genes in non-clinical population and to assess impact of neuropsychological and personality characteristics on these associations. One hundred healthy adults completed the BRIEF-A, personality inventories SPQ-74, STAI, MMPI, and neuropsychological tests for executive functions. Polymorphisms in the DRD4, COMT, DRD2, HTR2A, and SLC6A4 genes were genotyped. We revealed a significant main effect of the SLC6A4’s 5-HTTLPR polymorphism on BRIEF-A scores (F = 2.21, P = .018, η2 = .24). Among the BRIEF-A measures, the genotype effect was significant for the Plan/Organize (F = 7.34, P = .008, η2 = .07) and Task Monitor scales (F = 4.33, P = .04, η2 = .04), and the Metacognition index (F = 4.21, P = .043, η2 = .04). Carriers of the short allele reported fewer problems than homozygotes for the long allele. Correlations of the BRIEF-A measures with neuropsychological variables were weak, while those with personality characteristics were strong, with trait anxiety being the most powerful predictor of the BRIEF-A scores. However, the relationship between the 5-HTTLPR and BRIEF-A scores remained significant when trait anxiety was controlled for. The results suggest a potential role of the 5-HTTLPR in self-reported everyday task planning and monitoring (AU)


No disponible


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Polimorfismo Genético/genética , Polimorfismo Genético/fisiologia , Terapia Cognitivo-Comportamental/tendências , Dopamina/uso terapêutico , Serotonina/uso terapêutico , Neuropsicologia/métodos , Testes Psicológicos/normas , Neurociência Cognitiva/organização & administração , Neurociência Cognitiva/normas , Inventário de Personalidade/estatística & dados numéricos , Análise de Variância
17.
Rev. esp. enferm. dig ; 108(12): 819-921, dic. 2016.
Artigo em Espanhol | IBECS | ID: ibc-159633

RESUMO

Las intoxicaciones en edad pediátrica representan una causa frecuente de consulta en urgencias hospitalarias. Los productos elaborados con hierbas pueden resultar tóxicos para el lactante. Se han descrito ampliamente las propiedades neurotóxicas del anís estrellado (Illicium verum), producto clásicamente empleado para el tratamiento del cólico del lactante. La presentación de fallo hepático agudo por consumo de infusiones elaboradas con hierbas de anís es excepcional en nuestro entorno. Se describe el caso de un lactante de 4 meses con hipertransaminasemia, coagulopatía grave, hipoglucemia no cetósica, acidosis metabólica moderada y síntomas neurológicos con crisis convulsivas y nistagmo. Tras descartar etiología infecciosa, metabólica y autoinmune y realizar una anamnesis cuidadosa, la familia refería haber administrado al paciente durante los últimos dos meses una infusión diaria con anís estrellado y anís verde (Pimpinella anisum). Es de gran importancia resaltar el grave riesgo de administrar infusiones de hierbas caseras en el lactante (AU)


Intoxications in pediatric age represent a frequent cause of visit to the hospital emergency unit. Herb-made products can be toxic for the infant. The neurotoxic properties of the star anise (Illicium verum) have been widely described, although it is a classic product used to treat the infantile colic. Hepatic failure due to the consumption of anise herb elaborated infusions is presented as an exceptional finding in our environment. A case of a 4-month-old infant with hypertransaminasemia, severe coagulopathy, non ketotic hypoglycemia, moderated metabolic acidosis and neurologic symptoms such as seizures and nistagmus is described. After discarding infectious, metabolic and autoimmune etiology and through a meticulous anamnesis, the family referred having administered in the last two months a daily star anise and green anise (Pimpinella anisum) infusion to the patient. It is important to emphasize the serious risk of administering homemade herb infusions to infants (AU)


Assuntos
Humanos , Masculino , Lactente , Falência Hepática/complicações , Falência Hepática/diagnóstico , Falência Hepática/terapia , Anisum stellatum/efeitos adversos , Illicium/efeitos adversos , Plantas Medicinais/efeitos adversos , Plantas Medicinais/toxicidade , Chás de Ervas/efeitos adversos , Chás de Ervas/toxicidade , Ervanarias , Hipotonia Muscular/complicações , Febre/complicações , Febre/etiologia , Hipoglicemia/complicações , Dopamina/uso terapêutico , Clindamicina/uso terapêutico , Anamnese
18.
Nutr. hosp ; 33(6): 1461-1469, nov.-dic. 2016. tab
Artigo em Espanhol | IBECS | ID: ibc-159831

RESUMO

Introducción: cambios socioculturales como el incremento en el sedentarismo y el consumo de alimentos ricos en grasas y azúcares, sumado a características genéticas, han producido un aumento en las cifras de obesidad a nivel mundial. La evaluación temprana en niños, mediante el establecimiento de perfiles genéticos asociados a obesidad y a la regulación metabólica y hedónica de la alimentación, complementado con estudios de la conducta alimentaria, nos permitiría predecir la predisposición a la obesidad en etapas adultas. Objetivo: revisar los conceptos asociados a la conducta alimenticia, enfocándose en la regulación hedónica, que puede convertirse en un parámetro predictivo de obesidad en niños. Material y métodos: se revisó la bibliografía asociada a obesidad infantil y a la regulación homeostática y hedónica de la obesidad, como también parámetros génicos asociados a la obesidad. En la búsqueda de artículos se incluyó el trabajo en animales y humanos (adultos y niños, pero con énfasis en niños). Resultados: se analizaron los mecanismos celulares de la regulación de la ingesta, así como los estudios de conducta alimentaria en niños, entregando antecedentes y carencias en el desarrollo investigativo para la predicción de la obesidad infantil. Conclusión: la regulación hedónica de la ingesta alimenticia en niños, como perfiles genéticos asociados a receptores de dopamina, puede convertirse en un importante predictor de la obesidad. Es necesario incrementar el número de estudios que permitan definir de mejor forma, cuáles son los mejores parámetros para predecir el desarrollo de la obesidad adulta (AU)


Introduction: Socio-cultural changes such as increase in sedentary and high fat and sugar food intake, along with genetic characteristics, have produced an increase on obesity worldwide. Early evaluation in children, through the establishment of genetic profiles associated with obesity and metabolic and hedonic feeding regulation, complemented with feeding behavior studies would allow us to predict obesity predisposition at adult stages. Objective: To review concepts associated with feeding behavior regulation, focusing on hedonic control, which can become a predictive parameter of obesity in children. Material and methods: A review on child obesity papers and homeostatic and hedonic regulation of food intake literature was performed, including paper describing genetic parameters associated with obesity. In the articles search work on animals and humans (children and adults, but with emphasis on children) was included. Results: Cellular mechanisms of food intake regulation and also feeding behavior studies on children were analyzed, exposing background and deficiencies on research development for predicting child obesity. Conclusion: Hedonic regulation of feeding behavior in children, such as genetic profiles associated with dopamine receptors, can become important predictors of obesity. It is necessary to increase the number of studies that allows a better definition of which are the best parameters to predict obesity development in adulthood (AU)


Assuntos
Humanos , Masculino , Feminino , Criança , Comportamento Alimentar , Obesidade Pediátrica/epidemiologia , Sobrepeso/epidemiologia , Comportamento Alimentar , Fatores de Risco , Obesidade/prevenção & controle , Dopamina , Epidemiologia Molecular
19.
Rev. neurol. (Ed. impr.) ; 63(9): 415-421, 1 nov., 2016.
Artigo em Espanhol | IBECS | ID: ibc-157606

RESUMO

Introducción. La asimetría cerebral se puede definir como la existencia de diferencias funcionales, anatómicas o neuroquímicas entre los dos hemisferios cerebrales. Se trata de un fenómeno dinámico modulable por factores endógenos y exógenos. Su significado funcional está apenas aclarado y sólo lo está en algunos casos muy concretos como, por ejemplo, la relación existente entre el contenido cerebral lateralizado de dopamina y sus efectos motores, que se manifiesta especialmente en la enfermedad de Parkinson. Desarrollo. El contenido asimétrico cerebral de dopamina no sólo da lugar a efectos motores lateralizados, sino que se extiende a consecuencias autonómicas y de conducta igualmente lateralizadas. De hecho, la enfermedad de Parkinson se caracteriza por síntomas motores unilaterales, que surgen en las fases iniciales de la enfermedad, y por otros síntomas no motores, como alteraciones autonómicas o cognitivas, que también se manifiestan de forma lateralizada. Conclusiones. La asimetría cerebral ha sido un aspecto infravalorado a la hora de analizar la patogenia de las enfermedades cerebrales, y sólo en determinados casos, como en la enfermedad de Parkinson, se ha profundizado parcialmente en su estudio. Sin embargo, se ha puesto en evidencia que es necesario considerar este fenómeno para la adecuada comprensión de algunas patologías cerebrales, como es el caso de la enfermedad de Parkinson (AU)


Introduction. Brain asymmetry could be defined as the existence of functional, anatomic or neurochemical differences between both hemispheres. It is a dynamic phenomenon, regulated by endogenous and exogenous factors. Its functional significance is poorly clarified and is only partially understood in very specific cases such as the relationship between the lateralized brain content of dopamine and its motor effects which is specially patent in Parkinson’s disease. Development. The asymmetric brain content of dopamine not only displays lateralized motor effects but also behavioral and autonomic asymmetric consequences. In fact, Parkinson’s disease is characterized not only by unilateral motor symptoms that arise at the early stages, but has other non-motor symptoms such as autonomic or cognitive alterations that are also revealed asymmetrically. Conclusions. Brain asymmetry has been underestimated when analyzing the pathogeny of brain diseases and it has been partially studied only in some specific cases, such as Parkinson’s disease. However, in order to appropriately understand some brain diseases such as Parkinson’s disease, the need to consider this phenomenon has been highlighted (AU)


Assuntos
Humanos , Doença de Parkinson/fisiopatologia , Dopamina , Oxidopamina/farmacocinética , Dominância Cerebral/fisiologia , Neurônios Dopaminérgicos/fisiologia , Modelos Animais de Doenças , Sistema Nervoso Autônomo/fisiopatologia , Transtornos Cognitivos/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...